Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

m<sup>6</sup>A modification suppresses innate anti-tumour immunity in colorectal cancer by limiting alu-derived dsRNA accumulation.

Nature communications·2026

Same author

Hypoxia inducible factors regulate pneumovirus replication by enhancing innate immune sensing.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Single-cell analysis of signalling and transcriptional responses to type I interferons.

EMBO reports·2026

Same author

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

Nature communications·2026

Same author

Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity.

Science (New York, N.Y.)·2026

Same author

TMEM33 deletion potentiates anti-tumor CD8<sup>+</sup> T cell immunity.

bioRxiv : the preprint server for biology·2026

Same journal

Thyroid cancer-associated EZH1 Q571R mutation drives chromatin compaction and H3K27me3 invasion into active chromatin.

Molecular cell·2026

Same journal

Genome-wide rotational and translational phasing of nucleosomes with human transcription factors.

Molecular cell·2026

Same journal

Spliceosomal proofreading factors safeguard 3' splice-site fidelity and prevent proteotoxicity and inflammation.

Molecular cell·2026

Same journal

Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP.

Molecular cell·2026

Same journal

A bacterial reverse transcriptase: Protein-templated DNA synthesis fuels antiviral immunity.

Molecular cell·2026

Same journal

Tweezing apart ribosome heterogeneity.

Molecular cell·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 15, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Interferon induction held captive in tumor cells.

Anne Bridgeman¹, Jan Rehwinkel¹

¹Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.

|October 23, 2021

Summary

This summary is machine-generated.

Cancer-associated mutations in NF2 transform the tumor suppressor into a potent antagonist of innate immune signaling pathways. This finding reveals a novel mechanism by which cancer cells may evade immune detection and destruction.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Experiment Videos

Last Updated: Oct 15, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Area of Science:

Immunology
Oncology
Molecular Biology

Background:

Unusual nucleic acids, often found in transformed cells, can activate innate immunity.
The NF2 tumor suppressor gene plays a critical role in cell growth and survival.

Purpose of the Study:

To investigate the role of NF2 mutations in modulating innate immune responses to nucleic acids.
To understand how cancer-associated mutations in NF2 affect immune signaling.

Main Methods:

Analysis of NF2 mutations in cancer cell lines.
Assays to measure DNA- and RNA-induced innate immune signaling.
Functional studies to assess the antagonistic activity of mutated NF2.

Main Results:

Cancer-associated mutations in NF2 were found to confer potent antagonistic activity against DNA- and RNA-induced innate immune signaling.
Mutated NF2 proteins inhibit key pathways of the innate immune system.

Conclusions:

NF2 mutations can reprogram the tumor suppressor to actively suppress innate immunity.
This mechanism provides cancer cells with a means to evade immune surveillance, highlighting NF2 as a potential therapeutic target.